CTA095, a Novel Etk and Src Dual Inhibitor, Induces Apoptosis in Prostate Cancer Cells and Overcomes Resistance to Src Inhibitors

Etk is a non-receptor tyrosine kinase, which provides a strong survival signal in human prostate cancer cells. Src, another tyrosine kinase that cross-activates with Etk, has been shown to play an important role in prostate cancer metastasis. Herein, we discovered a new class of Etk inhibitors. With...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Guo, Wenchang, Liu, Ruiwu, Bhardwaj, Gaurav, Ma, Ai-Hong, Changou, Chun, Yang, Joy C., Li, Yuanpei, Feng, Caihong, Luo, Yan, Mazloom, Anisha, Sanchez, Eduardo, Wang, Yan, Huang, Wenzhe, Patterson, Randen, Evans, Christopher P., Lam, Kit S., Kung, Hsing-Jien
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2013
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3744530/
https://ncbi.nlm.nih.gov/pubmed/23967135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0070910
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים